封面
市场调查报告书
商品编码
1441272

全球核苷酸市场规模、份额、成长分析(按类型、按应用)- 2023-2030 年产业预测

Global Nucleotide Market Size, Share, Growth Analysis, By Type(Food Grade, Lab Grade), By Application(Pharmaceuticals, Food & beverage additive) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计2022年全球核苷酸市场规模为5.9572亿美元,从2023年的6.3146亿美元成长到2031年的10.00646亿美元,在预测期内(2024-2031年)预计复合年增长率为6%。

在全球范围内,核苷酸的使用在药品、食品和饮料、饲料和诊断研究等各个领域迅速增加,是市场扩张的驱动力。消费者对某些香料缺点的认识不断提高,推动了对核苷酸食用香料的需求,从而刺激了成长。特别值得注意的是核苷酸在医学中的应用不断升级,特别是在美国和加拿大等地区,这对该行业的扩张产生了积极影响。此外,由于动物健康问题,全球畜牧业需求激增,推动了对核苷酸食品添加剂的需求。此外,核苷酸在诊断研究中的作用不断扩大,使得检测疾病和测试各种病毒感染疾病和某些癌症变得更加容易,预计将在短期内进一步推动需求。

目录

执行摘要

  • 市场概况
  • 命运之轮

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模估算
  • 市场假设与限制

母市场分析

  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务

主要市场考察

  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • Start-Ups分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 主要投资分析
  • 关键成功因素
  • 竞争程度

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 监管形势
  • 波特的分析
  • 对未来中断的特殊考虑

全球核苷酸市场:按类型

  • 市场概况
  • 食品级
  • 实验室级
  • 工业级

全球核苷酸市场:按应用分类

  • 市场概况
  • 药品
  • 食品/饮料添加剂
  • 动物饲料添加剂
  • 其他的

全球核苷酸市场规模:按地区划分

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争形势

  • 前5名企业对比
  • 主要企业市场定位(2021年)
  • 主要市场参与者所采取的策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率(2021年)

主要企业简介

  • Thermo Fisher Scientific(US)
  • Merck KGaA(Germany)
  • Roche(Switzerland)
  • Agilent Technologies(US)
  • New England BioLabs(US)
  • Takara Bio(Japan)
  • Bio-Rad Laboratories(US)
  • Lonza Group(Switzerland)
  • Promega Corporation(US)
  • QIAGEN(Germany)
  • Creative BioMart(China)
  • Bioss(China)
  • GenScript(China)
  • BioVision(US)
  • Eurofins Scientific(France)
  • Enzo Biochem(US)
  • SERVA Electrophoresis(Germany)
  • IDT(US)
  • Life Technologies(US)
  • Sigma-Aldrich(US)
简介目录
Product Code: SQMIG15B2089

Global Nucleotide Market size was valued at USD 595.72 million in 2022 and is poised to grow from USD 631.46 million in 2023 to USD 1006.46 million by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

Globally, the burgeoning utilization of nucleotides across various sectors such as pharmaceuticals, food and beverage, animal feed, and diagnostic research is set to drive market expansion. Increased consumer awareness regarding the drawbacks of certain flavoring agents is propelling the demand for nucleotide-based flavor enhancers, thereby stimulating growth. Particularly notable is the escalating application of nucleotides in pharmaceuticals, notably in regions like the U.S. and Canada, which is positively impacting industry expansion. Moreover, the global surge in demand within the livestock sector due to animal health concerns is driving the need for nucleotide-based food additives. Additionally, the expanding role of nucleotides in diagnostic research, facilitating disease detection and testing for various viral infections or specific cancers, is expected to further fuel demand in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nucleotide Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nucleotide Market Segmental Analysis

The global nucleotide market is segmented on the basis of type, application, region. By type, the market is segmented into food grade, lab grade, industry grade. By application, the market is segmented into pharmaceuticals, food & beverage additive, animal feed additive, diagnostics research. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global Nucleotide Market

The ongoing progress in pharmaceutical research and development drives the global nucleotide market forward, as nucleotides prove indispensable in various facets such as drug discovery, gene therapies, and personalized medicine. This essential role within the pharmaceutical industry fuels the increasing demand for nucleotides worldwide.

Restraints in the Global Nucleotide Market

Despite increasing awareness, a significant portion of consumers remain uninformed about nucleotides and their beneficial impacts. The potential for market growth could be hindered by this lack of comprehension, particularly in regions where the consumption of functional foods is not widespread.

Market Trends of the Global Nucleotide Market

The increasing consumer inclination towards natural and clean-label ingredients has spurred a growing demand for nucleotides sourced from natural origins, prompting manufacturers to prioritize sustainable and organic sourcing practices in response to this trend.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Nucleotide Market by Type

  • Market Overview
  • Food Grade
  • Lab Grade
  • and Industry Grade

Global Nucleotide Market by Application

  • Market Overview
  • Pharmaceuticals
  • Food & beverage additive
  • Animal feed additive
  • and Others

Global Nucleotide Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Thermo Fisher Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England BioLabs (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative BioMart (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioss (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioVision (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Enzo Biochem (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SERVA Electrophoresis (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDT (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Life Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sigma-Aldrich (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments